Global Edition
Global Edition
UK Edition
EU Edition
US Edition

Understand the story, not the spin.

Markets

Novo Nordisk A/S News

Recent Verilumia coverage about Novo Nordisk A/S (NVO), including reporting-tone insights and market listing information.

Novo reports weight loss after switch to Wegovy pill

Novo reports weight loss after switch to Wegovy pill

Novo Nordisk said a real-world study found that 194 people who switched from injectable obesity medicines to its daily Wegovy pill lost an average of 4.1% of their body weight over three months. Nearly 41% of...

Coverage Mix 7 source articles
Left 17% Centre 66% Right 17%
Now playing
0:00 / 0:00